1. A Model‐Based Illustrative Exploratory Approach to Optimize the Dosing of Peg‐IFN/RBV in Cirrhotic Hepatitis C Patients Treated With Triple Therapy. (30th December 2014) Authors: Laouénan, C; Guedj, J; Peytavin, G; Nguyen, TH Tram; Lapalus, M; Khelifa‐Mouri, F; Boyer, N; Zoulim, F; Serfaty, L; Bronowicki, J‐P; Martinot‐Peignoux, M; Lada, O; Asselah, T; Dorival, C; Hézode, C; Carrat, F; Nicot, F; Marcellin, P; Mentré, F Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 4:Number 1(2015:Jan.) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Sustained virological response to Do hepatitis C DAA treatments in migrants and non-migrants groups. (13th November 2019) Authors: Djaogol, T; Fontaine, H; Baudoin, M; Protopopescu, C; Marcellin, F; Dorival, C; Bourlière, M; Delarocque-Astagneau, E; Carrat, F; Carrieri, P Journal: European journal of public health Issue: Volume 29(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗